Developing a new tumor model is time-consuming and requires both significant investment and skilled resources to characterize. Horizon Discovery offers a comprehensive xenograft tumor model growth service, by simply providing your dissociated cells or tissue our state of the art facility enables us to provide characterization of the tumor growth.
What is included:
As a result, your model will be fully characterized leaving you well prepared for the next steps in your tumor research. Horizon Discovery offers every service you need for preclinical efficacy assessment, from compound screening, using Horizon’s high-throughput screening service for identifying “hits” to conducting in-vivo efficacy studies. At the end, you will have a fully vetted compound for you to make a well informed decision about moving your compound into the clinic.
You will need to provide the cells or tissue that you require tumor growth for. Study timescales will vary depending on cells or tumor type.
Horizon Discovery has a commitment to using state of the art sterile animal housing and fully trained technicians through:
This investment means that we adhere to the highest quality of standards to ensure a pathogen-free facility.
Contact us to discuss your project needs